FRM
DPLO

Fox Run Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Fox Run Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-28,913
Closed -$168K – 711
2019
Q1 		$168K Buy
28,913
+14,504
+101% +$150K 0.09% 405
2018
Q4 		$194K Buy
+14,409
New +$243K 0.1% 419
2018
Q3 		– Sell
-8,968
Closed -$229K – 922
2018
Q2 		$229K Buy
+8,968
New +$209K 0.07% 532
2018
Q1 		– Sell
-12,172
Closed -$244K – 1024
2017
Q4 		$244K Buy
+12,172
New +$239K 0.07% 524
2017
Q1 		– Sell
-10,100
Closed -$127K – 818
2016
Q4 		$127K Buy
+10,100
New +$188K 0.07% 459

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fox Run Management's DPLO Position: Q2 2019 in Review

Fox Run Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2019, closing a stake of 28,913 shares — an estimated $168K sold.

Fox Run Management first reported a position in DPLO in Q4 2016 and held it in 5 quarters. The position peaked at $244K in Q4 2017. 131 funds tracked by Wall St. Rank hold DPLO as of Q2 2019.

  • Fox Run Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2019 after selling out during the quarter.
  • Fox Run Management sold 28,913 DIPLOMAT PHARMACY, INC. shares in Q2 2019, an estimated $168K.
  • Fox Run Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2016 and held it in 5 quarters.
  • Fox Run Management's DIPLOMAT PHARMACY, INC. position peaked at $244K in Q4 2017.
  • 131 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2019.

Based on Fox Run Management's 13F filing for Q2 2019, filed 17 Jul 2019.